Led by Caroline Huber, Associate Director of Policy and Economics, a surprising new study was recently published in The Journal of Infectious Diseases, estimating the overlooked social, economic and health impacts of the 2013-2016 West Africa Ebola crisis.
Senior Research Economist James Baumgardner will be presenting “CAR-T Therapy Displays Favorable Gains in Health Outcomes and Competitive Cost-Effectiveness When Compared with Past Innovative Cancer Treatments” at the American Society of Hematology (ASH) 60thAnnual Meeting and Exposition, taking place from December 1-4 in San Diego, CA.
Lessons Learned from the Oncology Care Model Implementation: Maximizing the Value of Health Economics Evidence—presented by PHE Senior Economist and former Congressional Budget Office Deputy Assistant Director, Dr. James Baumgardner, and PHE Scientific Advisor, Dr. Wade Aubry, former Chief Medical Officer of Blue Shield of California. […]
The ISPOR 23rd Annual International Meeting took place in Baltimore, Maryland from May 19-23, and Precision Health Economics (PHE) and Precision Xtract were both there to meet with you and share our expertise. […]
For more information, or to learn how to change your cookies preferences, please click here.